Stock Analysis

MSCI Full Year 2024 Earnings: EPS Beats Expectations

NYSE:MSCI
Source: Shutterstock

MSCI (NYSE:MSCI) Full Year 2024 Results

Key Financial Results

  • Revenue: US$2.86b (up 13% from FY 2023).
  • Net income: US$1.11b (down 3.4% from FY 2023).
  • Profit margin: 39% (down from 45% in FY 2023). The decrease in margin was driven by higher expenses.
  • EPS: US$14.09 (down from US$14.46 in FY 2023).
revenue-and-expenses-breakdown
NYSE:MSCI Revenue and Expenses Breakdown February 13th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

MSCI EPS Beats Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 1.5%.

The primary driver behind last 12 months revenue was the Index segment contributing a total revenue of US$1.60b (56% of total revenue). The most substantial expense, totaling US$425.1m were related to Non-Operating costs. This indicates that a significant portion of the company's costs is related to non-core activities. Explore how MSCI's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 7.9% p.a. on average during the next 3 years, compared to a 5.8% growth forecast for the Capital Markets industry in the US.

Performance of the American Capital Markets industry.

The company's shares are down 1.6% from a week ago.

Risk Analysis

You should always think about risks. Case in point, we've spotted 1 warning sign for MSCI you should be aware of.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NYSE:MSCI

MSCI

Provides critical decision support tools and solutions for the investment community to manage investment processes worldwide.

Average dividend payer with limited growth.

Community Narratives

AstraZeneca's Oncology and Obesity Innovations Will Drive Revenue Growth by 10%
Fair Value SEK 2.55k|36.403% undervalued
Unike
Unike
Community Contributor
Leading the Charge in SME SaaS Innovation
Fair Value SEK 100.02|25.014999999999997% undervalued
Investingwilly
Investingwilly
Community Contributor
Brookfield Corporation is a solid BUY for a long-term portfolio
Fair Value CA$82.23|1.7389999999999999% overvalued
Jonataninho
Jonataninho
Community Contributor